<?xml version="1.0" encoding="UTF-8"?>
<document id="29762727">
	<sentence id="s1" text="In lung adenocarcinoma (LADC), specific thyroxin kinase inhibitors against EGFR mutations and ALK fusions are used as a standard treatment regimen and show significant positive efficacy.">
		<entity id="s1.e1" charOffset="3-22"
			type="HP" text="lung adenocarcinoma" ontology_id="HP_0030078"/>
		<entity id="s1.e2" charOffset="75-79"
			type="GENE" text="EGFR" ontology_id="1956"/>
		<entity id="s1.e3" charOffset="94-97"
			type="GENE" text="ALK" ontology_id="238"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
	</sentence>
</document>
